---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-036307"
form_type: "8-K"
ticker: "VYGR"
cik: "0001640266"
company_name: "Voyager Therapeutics, Inc."
filed_at: "2022-03-22T23:59:59+00:00"
generated_at: "2026-06-26T21:00:40.592597+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Voyager Therapeutics appoints Alfred Sandrock as President and CEO, effective March 22, 2022

## Summary
- Alfred Sandrock, former Biogen EVP of R&D, appointed President and CEO effective March 22, 2022.
- Sandrock receives base salary of $600,000, signing bonus of $50,000, target annual bonus of 55% of base salary.
- Equity grants: stock option for 940,600 shares and RSU for 100,000 shares, both vesting over four years.
- Michael Higgins ceases as Interim CEO, remains Chairman and independent director; receives $30,000 transition retainer.

## SEC filing metadata
- accession: 0001104659-22-036307
- form_type: 8-K
- ticker: VYGR
- cik: 0001640266
- company_name: Voyager Therapeutics, Inc.
- filed_at: 2022-03-22T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1640266/000110465922036307/0001104659-22-036307-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1640266/000110465922036307/tm229951d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-036307
- JSON: https://secwatch.observer/filing/0001104659-22-036307.json
- Plain text: https://secwatch.observer/filing/0001104659-22-036307.txt

## Key facts
- Executive change
  Alfred Sandrock was appointed as President and Chief Executive Officer at Voyager Therapeutics, Inc..
  - Action: appointed
  - Role: President and Chief Executive Officer
  source text: Appointment of Alfred Sandrock, M.D., Ph.D. as President and Chief Executive Officer
  evidence_url: https://www.sec.gov/Archives/edgar/data/1640266/000110465922036307/0001104659-22-036307-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.